SHS Gesellschaft fur Beteiligungsmanagement

About The Fund

SHS Gesellschaft fur Beteiligungsmanagement is a prominent private equity and venture capital firm that has been an active participant in the healthcare investment landscape since 1993. With a strategic focus on the healthcare, life sciences, medical technology, diagnostics, biotechnology, and pharmaceutical sectors, SHS is known for supporting the rise of European healthcare champions. Operating from its headquarters in Tuebingen, Germany, the firm has successfully carved out a leading position in the German healthcare-dedicated private equity fund space. SHS has a comprehensive investment approach, offering not just capital but also a deep and beneficial network developed over more than three decades in the healthcare sector. Their expertise includes intricate knowledge and advisory capabilities in market access, reimbursement, marketing and sales, mergers and acquisitions, and exit strategies. Throughout its 30 years of history, SHS has launched six fund generations, conducted over 70 investments, and executed more than 45 exits. The current SHS VI fund volume is approximately 270 million euros. The firm sees a robust deal flow, with over 1,000 cases per year, and targets transactions with enterprise values of up to 150 million euros. Their equity investments typically range from 10 to 50 million euros. SHS's investment focus is on growth-stage healthcare companies in Europe, providing financial resources to small and medium-sized enterprises as well as scale-up companies experiencing rapid growth. SHS's approach is flexible, engaging in both majority and minority investment situations. For growth companies, SHS looks for revenue in the seven-digit figures and double-digit growth rates. The firm also extends an invitation to investors interested in partnering with them or joining its exclusive healthcare network comprising leading European scientists, entrepreneurs, and investors.